TrialDrug safety2009

Safety of rupatadine administered over a period of 1 year in the treatment of persistent allergic rhinitis: a multicentre, open-label study in Spain.

Antonio Valero et al.PubMed ↗Publisher ↗

No numbers read from the abstract.